Blog
Updates and more on the
Company Blog
The PRECIOUS Study – an update on PredictImmune’s observational study to demonstrate effectiveness of PredictSURE IBD in IBD patients in North America
In our most recent blog, we provide an update on the progress of the PRECIOUS study, discuss overcoming the challenges of recruiting to the study over the last few years and invite you to get involved and support the completion of the study…
The PROFILE Trial – progress report on the first biomarker stratified randomised clinical trial (RCT) for patients living with Crohn’s disease (CD)
The PROFILE Trial – progress report on the first biomarker stratified randomised clinical trial (RCT) for patients living with Crohn’s disease (CD)...
PredictSURE® IBD and the PROFILE trial – a patient perspective
PredictSURE® IBD and the PROFILE trial - a patient perspectiveLouise Hunt, Young Crohn’s Imagine this situation, you get diagnosed with a lifelong...
Would things have been different if I’d had a prognosis for my IBD?
Would things have been different if I’d had a prognosis for my IBD?Sahara Fleetwood-Beresford - IBD Superheroes What’s a prognostic test? Prognosis...
Why “the new normal” can be better than the past for patients with inflammatory bowel disease
Why “the new normal” can be better than the past for patients with inflammatory bowel diseaseWith the acceleration of remote patient management, the...
Counting the Cost of Biologic Therapy in IBD
Counting the Cost of Biologic Therapy in IBDInflammatory bowel disease (IBD) puts a significant burden on healthcare systems due to its chronic...
Pregnancy outcomes in women with IBD: a 10‐year nationwide population‐based cohort study
Pregnancy outcomes in women with IBD: a 10‐year nationwide population‐based cohort studyCrohn’s disease (CD) and ulcerative colitis (UC) often...
Paul Lyons – VP Platform Delivery
Eoin McKinney – CSO
Andy Sandham, Chairman
